Cart

Selected lab test is not available at this location

ROMA ((Risk of Ovarian Malignancy Algorithm) Test

About Test

 The risk of Ovarian Malignancy Algorithm (ROMA) test is intended to aid in assessing the risk of ovarian cancer in women with a pelvic mass based on the patient's HE4 and CA125 levels, and their menopausal status. Women with ROMA™ levels above the cutoff have an increased risk of ovarian cancer. ROMA™ must be interpreted in conjunction with an independent clinical and radiological assessment.  

Components: CA-125, HE4 OVARIAN CANCER

Cart

Selected lab test is not available at this location